These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 12541170

  • 1. [Acute episode].
    Schölmerich J, German Society for Digestive and Metabolic Diseases.
    Z Gastroenterol; 2003 Jan; 41(1):27-30. PubMed ID: 12541170
    [No Abstract] [Full Text] [Related]

  • 2. [Maintaining a remission].
    Fleig WE, German Society for Digestive and Metabolic Diseases.
    Z Gastroenterol; 2003 Jan; 41(1):36-42. PubMed ID: 12541172
    [No Abstract] [Full Text] [Related]

  • 3. [New research results give hope. Causal therapy of Crohn disease in sight].
    MMW Fortschr Med; 2004 Apr 01; 146(14):42-3. PubMed ID: 15344754
    [No Abstract] [Full Text] [Related]

  • 4. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
    MMW Fortschr Med; 2009 May 07; 151(19):38-9. PubMed ID: 19827443
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of Crohn's disease].
    Beglinger Ch.
    Ther Umsch; 2003 Mar 07; 60(3):159-63. PubMed ID: 12693319
    [Abstract] [Full Text] [Related]

  • 7. [Drug therapy of Crohn's disease: slowly increase or start aggressively right away?].
    Bischoff A.
    MMW Fortschr Med; 2010 Jan 14; 152(1-2):20. PubMed ID: 20302159
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Paradigmatic shift in drug treatment of Crohn disease].
    Munck LK.
    Ugeskr Laeger; 2005 Aug 15; 167(33):3013. PubMed ID: 16109239
    [No Abstract] [Full Text] [Related]

  • 11. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
    Feagan BG, Sandborn WJ.
    Rev Gastroenterol Disord; 2002 Aug 15; 2 Suppl 2():S9-15. PubMed ID: 12478239
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Ulcerative colitis. Acute episode].
    Reissmann A, Bischoff SC, Fleig W.
    Z Gastroenterol; 2004 Sep 15; 42(9):994-8. PubMed ID: 15455271
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Ulcerative colitis. Maintenance therapy].
    Kruis W, Schreiber S.
    Z Gastroenterol; 2004 Sep 15; 42(9):1011-4. PubMed ID: 15455275
    [No Abstract] [Full Text] [Related]

  • 18. Immunosuppressive treatments in Crohn's disease induce myelodysplasia and leukaemia.
    Piccin A, Cortelazzo S, Rovigatti U, Bourke B, Smith OP.
    Am J Hematol; 2010 Aug 15; 85(8):634. PubMed ID: 20568248
    [No Abstract] [Full Text] [Related]

  • 19. [Chronically active Crohn's disease].
    Hoffmann J, Zeitz M, German Society for Digestive and Metabolic Diseases.
    Z Gastroenterol; 2003 Jan 15; 41(1):31-5. PubMed ID: 12541171
    [No Abstract] [Full Text] [Related]

  • 20. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
    Dilger K, Schaeffeler E, Lukas M, Strauch U, Herfarth H, Müller R, Schwab M.
    Ther Drug Monit; 2007 Feb 15; 29(1):1-5. PubMed ID: 17304143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.